From October 1, 2023 to March 31, 2024, the company has repurchased 35,851,329 shares, representing 4.74% for CNY 222.07 million. With this, the company has completed the repurchase of 49,999,929 shares, representing 6.59% for CNY 322.09 million under the buyback announced on May 9, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.9 CNY | +0.17% | 0.00% | -14.49% |
1st Jan change | Capi. | |
---|---|---|
-14.49% | 585M | |
+20.37% | 43.54B | |
+18.30% | 21.78B | |
+17.85% | 15.38B | |
+25.55% | 15.12B | |
+60.99% | 13.36B | |
-0.05% | 6.79B | |
-14.84% | 6.38B | |
-8.87% | 5.73B | |
+8.17% | 5.32B |
- Stock Market
- Equities
- 600351 Stock
- News Yabao Pharmaceutical Group Co., Ltd
- Tranche Update on Yabao Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on May 9, 2023.